Barbital was formerly used clinically as a hypnotic or sedative. However, it has been phased out due to its weak efficacy, high incidence of adverse reactions, safety concerns, and high potential for dependence.

To support law enforcement efforts, AccuSift provides high-performance competitive antibody pairs for barbital detection. These reagents offer exceptional inter-batch consistency and are optimized specifically for IVD kit development, including lateral flow assays, chemiluminescence, ELISA, and POCT platforms. Featuring high affinity and high specificity, they enable rapid and reliable detection.

Sensitivity: Colloidal Gold: 10 ppb